The Drug-Induced Cardiotoxicity Website and App
Frequency - Incidence
Incidence of cardiac adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for cardiac adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pneumonitis (interstitial lung disease/ILD)
Publications
Kirby S, Satoskar A, Brodsky S, Pope-Harman A, Nunley D, Hitchcock C, Pelletier R, Ross P, Nadasdy T, Shilo K
Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.
Diagnostic pathology. 2012;7:25
Sirolimus-induced pneumonitis after renal transplantation: a single-center experience.
Transplantation proceedings. 2012;44(1):161-3
Interstitial pneumonitis is a frequent complication in liver transplant recipients treated with sirolimus.
Irish journal of medical science. 2012;181(2):231-5
Persistent dyspnea in a 59-year-old woman receiving immunosuppressants.
Chest. 2011;140(3):818-822
Risk factors for and management of sirolimus-associated pneumonitis in kidney transplant recipients.
Nature clinical practice. Nephrology. 2008;4(5):250-1
Pneumonitis associated with sirolimus: clinical characteristics, risk factors and outcome--a single-centre experience and review of the literature.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2007;22(12):3631-7
Delgado JF, Torres J, José Ruiz-Cano M, Sánchez V, Escribano P, Borruel S, María Cortina J, de la Calzada CS
Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2006;25(9):1171-4
Sirolimus-induced pulmonary hypersensitivity associated with a CD4 T-cell infiltrate.
Chest. 2006;129(6):1718-21
Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients.
Annals of internal medicine. 2006;144(7):505-9
Reversible sirolimus-associated pneumonitis after heart transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2006;25(2):241-4
Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.
Clinical transplantation. 2005;19(5):698-703
Patterns of pulmonary complications associated with sirolimus.
Respiration; international review of thoracic diseases. 2006;73(3):367-74
Sirolimus for pediatric liver transplant recipients with post-transplant lymphoproliferative disease and hepatoblastoma.
Pediatric transplantation. 2004;8(3):243-8
Sirolimus-associated pulmonary toxicity.
Transplantation. 2004;77(8):1215-20
Sirolimus-induced pneumonitis: three cases and a review of the literature.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2004;4(1):137-9